Table 5.

Microvascular characteristics of groups

Variable	Group	Values			p*
		Me	Q1-Q3	n
MVD	Without metastasis	9	7-11	53	0.158
	With metachronous metastasis	11	8-13	45
	With synchronous metastasis	10	8-12	53
PIMs	Without metastasis	2	1-3	53	<0.001
	With metachronous metastasis	7	5-10	45
	With synchronous metastasis	8	6-10	53

^*Kruskal-Wallis test.

MVD: Microvascular Density; PIMs: Pericyte-Impaired Microvessels.